Legal Repercussions for Actinium Pharmaceuticals An Analysis of Recent Developments and Market Performance
In a significant development within the pharmaceutical sector, Gainey McKenna & Egleston has announced the initiation of a class-action lawsuit against Actinium Pharmaceuticals, Inc. (NYSE: ATNM). The case, formally fil...
Mar 28, 2025
• Major Pharmaceutical Preparations Industry
Announcement
Class ActionMonday Apitoria Pharma Biocon Writer F
